10 principais hra-pharma.com concorrentes

iba-worldwide.com

FY25 results webcast to take place on Friday, 27 March 2026 at 3pm CET Louvain-la-Neuve, Belgium, 13 March 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2025 on Friday, 27 March 2026 at 7am CET.Conference Call InformationIBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session.The conference call will be held on Friday,27 March 2026 at 3pm CET / 2pm BST / 10am EDT / 7am PDT as a Teams webinar. To attend the webcast, register via this link. The presentation will be available on IBA’s investor relations website and on: https://www.iba-worldwide.com/iba-full-year-2025-results-press-release-conference-call  shortly before the call.To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.***ENDS***About IBAIBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as one of the most advanced forms of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com

lnkintl.com

Deliver trusted solutions with LNK International, Inc., one of the leaders in quality, affordable over-the-counter pharmaceuticals worldwide.

geminipharm.com

Privacy Policy This privacy policy has been compiled to better serve those who are concerned with how their ‘Personally identifiable information’ (PII) is being used online. PII, as used in US privacy law and information security, is information that can be used on its own or with other information to identify, contact, or locate a […]

globalphar.com

impax laboratories is an integrated specialty pharmaceutical company focused on developing, manufacturing and marketing generic and specialty pharmaceutical products.

cebert.com

Offering Take-Home Bottles and Closures to Opioid Treatment Programs

noven.com

Our Story Noven – 1987 to Today Noven's history began in 1987 in Miami, Florida, with the mission to develop differentiated prescription transdermal drug delivery systems (patches) to support patients across a range of therapeutic…

keryx.com

Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.